Objective.-To evaluate the economic consequences of a routine varicella vaccination program that targets healthy children.
Methods.-Decision analysis was used to compare the costs, outcomes, and cost-effectiveness of a routine vaccination program with no intervention.
Clinical outcomes were based on a mathematical model of vaccine efficacy that relied on published and unpublished data and on expert opinion.
Medical utilization rates and costs were collected from multiple sources, including the Kaiser Permanente Medical Care Program and the California Hospital Discharge Database.
Results.-A routine varicella vaccination program for healthy children would prevent 94% of all potential cases of chickenpox, provided the vaccination coverage rate is 97% at school entry.
Mots-clés Pascal : Economie santé, Virose, Prévention, Enfant, Varicelle, Etats Unis, Programme sanitaire, Analyse coût efficacité, Vaccination, Infection, Homme, Amérique du Nord, Amérique
Mots-clés Pascal anglais : Health economy, Viral disease, Prevention, Child, Varicella, United States, Sanitary program, Cost efficiency analysis, Vaccination, Infection, Human, North America, America
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0295601
Code Inist : 002B30A03B. Création : 199406.